983 resultados para FL BoG
Resumo:
Soluções de iodeto de sódio (NaI) e de politungstato de sódio (PTS) têm sido utilizadas, de forma indistinta, no fracionamento densimétrico da matéria orgânica (MO) do solo. O objetivo deste estudo foi avaliar o efeito desses dois produtos em soluções de mesma densidade (1,80 kg L-1), bem como do aumento da densidade da solução de PTS (2,0 e 2,2 kg L-1), na obtenção de C na fração leve (FL) da MO do solo. As características estruturais da FL obtida com as diferentes soluções também foram avaliadas por ressonância magnética nuclear do 13C (RMN-13C) neste estudo, o qual foi realizado com amostras da camada de 0-5 cm de dois solos brasileiros (PVd-Argissolo Vermelho e LVd-Latossolo Vermelho). A dispersão do solo foi realizada com ultra-som (250 J mL-1 no PVd e 450 J mL-1 no LVd); a suspensão de 20 g de solo e 80 mL-1 de solução foi centrifugada (2.000 g, 90 min), e a FL, obtida pela filtragem do sobrenadante em filtro de fibra de vidro, sendo o C desta fração analisado por combustão seca (Shimadzu TOC-V CSH). O uso da solução de PTS aumentou a recuperação de C da FL em 152 % no PVd e em 166 % no LVd, em comparação à solução de NaI de mesma densidade (1,8 kg L-1). O incremento da densidade da solução de PTS também aumentou a obtenção de C na FL, o qual foi mais expressivo na densidade de 1,8 para 2,0 kg L-1 (57 % em ambos os solos) do que de 2,0 para 2,2 kg L-1 (21 % no PVd e 5 % no LVd). Com base nos teores de Fe e C da fração argila, estimou-se que a contaminação da FL com C da fração argila, quando do uso das soluções de PTS, variou de 1,9 a 3,5 % no LVd e de 6,8 a 10,4 % no PVd, os quais foram considerados baixos perante o alto percentual de incremento na recuperação de C na FL. O incremento da razão C Alquil/C-O-alquil e do C-carbonila na análise de RMN-13C sugere incremento na recuperação de FL em estádios mais avançados de decomposição com o uso de PTS e incremento da densidade da solução, tendo sido esses resultados mais expressivos no LVd. Com base no incremento da obtenção de C e na baixa contaminação da FL com C da fração argila, recomenda-se o uso da solução de PTS 2,0 kg L-1 em estudos de fracionamento densimétrico da MO do solo.
Resumo:
Este estudo teve como objetivo avaliar o efeito de espaçamentos de plantio do cafeeiro sobre os estoques de carbono e nitrogênio e sobre os teores e distribuição de C em frações da matéria orgânica de um Latossolo Vermelho distroférrico típico. Foi avaliado um experimento conduzido durante 11 anos na Fazenda Experimental da EPAMIG, em Machado (MG), cujos tratamentos consistiram da combinação de quatro espaçamentos entre linhas (2,0, 2,5, 3,0 e 3,5 m) com três espaçamentos entre plantas (0,5, 0,75 e 1,0 m) de cafeeiro. Uma área sob mata nativa próxima ao experimento foi utilizada como referência. Para avaliação dos estoques de C orgânico (CO) e N total (NT) e realização do fracionamento físico-densimétrico da matéria orgânica, as amostras de solo foram coletadas na entrelinha (EL) e na projeção da copa (PC) do cafeeiro. Os estoques de CO e os teores de C-FL na entrelinha do cafeeiro são iguais ou superiores àqueles determinados para as amostras da projeção da copa. Os estoques totais de CO e de NT e as outras frações da matéria orgânica do solo avaliadas não são influenciados pelo espaçamento entre plantas e entre linhas, pela área de planta e pela população de cafeeiro.
Resumo:
O avanço das fronteiras agrícolas, caracterizado pela substituição de ecossistemas naturais por áreas cultivadas, vem se intensificando nas últimas décadas, acarretando alterações na qualidade do solo e na dinâmica da matéria orgânica do solo (MOS). Assim, o estudo do impacto da adoção de diferentes sistemas de manejo é essencial na definição de melhores estratégias de uso do solo. Este estudo teve por objetivo avaliar diferentes frações da MOS e os estoques de C e N de Latossolo Vermelho distroférrico típico muito argiloso submetido a diferentes sistemas de uso e manejo: mata nativa (MTN), eucalipto (EUC), pinus (PIN), pastagem (PAS), milho no sistema de cultivo mínimo (MCM) e milho no sistema plantio convencional (MPC). As amostras de solo foram coletadas em setembro de 2004, nas profundidades de 0-10, 10-20 e 20-40 cm, para avaliação dos estoques de carbono orgânico (CO) e N total (NT); de 0-5 e 0-10 cm, para realização do fracionamento físico-densimétrico da MO; e de 0-5 cm, para avaliação do C da biomassa microbiana (Cmic). O estoque de CO na área de eucalipto foi maior do que o determinado na área de mata. A proporção relativa do CO nas frações da MOS aumentou na seguinte ordem: C-argila > C-silte > C-areia > C FL. A maior parte (> 90 %) do CO está associada à fração pesada da MOS, com valores próximos a 98 % nos sistemas cultivados com milho (MPC e MCM). Em relação aos teores de CO, o Cmic e o C da fração leve (C FL) são indicadores mais sensíveis das alterações decorrentes da adoção de diferentes sistemas de uso e manejo sobre os compartimentos da matéria orgânica do Latossolo.
Resumo:
A matéria orgânica leve tem se mostrado um indicador precoce das mudanças na matéria orgânica do solo (MOS) acarretadas por diferentes usos e sistemas de manejo. Várias soluções são empregadas na sua separação, mas pouco se sabe sobre o efeito delas na quantidade e qualidade da fração extraída, tampouco se conhecem as possíveis interferências que a solução de separação pode ocasionar na posterior quantificação do carbono (C) orgânico. Assim, foram selecionados 20 solos com diferentes teores de argila e que se encontravam sob diferentes usos, onde foram coletadas amostras, em três repetições, na profundidade de 0-20 cm. Depois de secas ao ar, destorroadas, passadas em peneira com malha de 2 mm e homogeneizadas, retiraram-se subamostras para determinação do teor de argila e para realização do fracionamento densimétrico da MOS. Do fracionamento densimétrico com água ou NaI (1,8 kg L-1), foram obtidas a fração leve (FL) e a fração pesada (FP) da MOS. O teor de C da FL foi determinado por combustão via seca, em analisador elementar (CHN), e o teor de C da FP foi determinado por oxidação via úmida com aquecimento externo, segundo Yeomans & Bremner (1988) (Y & B), e em analisador elementar (CHN). Adicionalmente, foi determinado o teor equivalente em C orgânico por via úmida em soluções-padrão com NaI em diferentes concentrações. Foi observado que a quantidade da FL extraída com NaI foi, em média, 4,86 vezes maior em relação à extraída com água destilada. A relação C:N da fração extraída com NaI foi, em média, 1,85 vez superior à apresentada pela extração com água destilada, mas com grande variação entre solos. Com relação à FP da MOS, o teor de C determinado por Y & B foi similar quando se procedeu à separação densimétrica com água, mas foi cerca de 1,5 vez superior ao determinado pelo CHN quando esta fração foi separada com NaI, indicando que houve superestimação do teor de C orgânico devido à interferência do NaI. Esse fato foi confirmado pelo aumento linear no consumo de Cr2O7-2 quando da presença de concentrações crescentes de NaI em soluções isentas de C. Dessa forma, a extração com NaI recupera maior proporção da FL, mas que difere em qualidade daquela extraída com água. Além disso, algum possível resíduo de NaI usado na separação pode interferir na quantificação do C orgânico quando este for determinado por dicromatometria. Resultados de estudo adicional sugerem que cada mol de I- consome aproximadamente 1 mol de Cr2O7-2.
Resumo:
Background In rheumatoid arthritis (RA), non-professional antigen presenting cells (APCs) such as fi broblast-like synoviocytes (FLS) can express MHC class II (MHCII) molecules and function as non-professional APCs in vitro.Objective To examine the regulation of MHCII expression in FLS and to investigate the role of FLS as non-professional APCs in collagen-induced arthritis (CIA). Methods Expression of MHCII, CIITA and Ciita isoforms pI, pIII and pIV was examined by RT-qPCR, immunohistochemistry and fl ow cytometry in human synovial tissues, arthritic mouse joints and human as well as mouse FLS. CIA was induced in mice knockout for the isoform IV of Ciita (pIV-/-), in pIV-/- mice transgenic for CIITA in the thymus (pIV-/- K14 CIITA) and in control littermates in the DBA/1 background by immunising with bovine collagen type II (CII) in complete Freund's adjuvant.Results HLA-DRA, total CIITA and CIITA pIII mRNA levels were signifi cantly increased in the synovial tissues from RA compared to osteoarthritis patients. Human FLS expressed surface MHCII via CIITA pIII and pIV, while MHCII expression in murine FLS was entirely mediated by pIV. pIV-/- mice lacked both inducible MHCII expression on non-professional APCs including FLS, and in the thymic cortex. The thymic defect in pIV-/- mice impaired CD4+ positive selection, thus protecting pIV-/- mice from CIA by preventing CD4+ T cells immune responses against CII and blocking the release of IFN-γ and IL-17 in ex vivo stimulated lymph node cells. The production of T dependent, arthritogenic anti-CII antibodies was also impaired in pIV-/- mice. A normal thymic expression of MHCII and CD4+ T cell repertoire was obtained in pIV-/- K14 CIITA Tg mice. Immune responses against CII were restored in pIV-/- K14 CIITA Tg mice, as well as the arthritis incidence and clinical severity despite the lack of MHCII expression by mouse FLS. At histology, infl ammation andneutrophils infi ltration scores were not reduced in pIV-/- K14 CIITA Tg mice, while the bone erosion score was signifi cantly lower than in controls.Conclusion Over expression of MHCII is tightly correlated with CIITA pIII in the arthritic human synovium. MHCII is induced via CIITA pIII and pIV in human FLS. In the mouse, MHCII expression in the thymic cortex and in FLS is strictly dependent upon Ciita pIV. The lack of Ciita pIV in the periphery of pIV-/- K14 CIITA Tg mice lowered the bone erosion score but did not signifi cantly protect from infl ammation and autoimmune responses in CIA.
Resumo:
Radioimmunotherapies with Zevalin® (RIT-Z) showed encouraging results in patients with relapsed/refractory follicular lymphoma (FL), leading frequently to failure-free intervals longer than those achieved by the last previous therapy. We compared time-to-event variables obtained before and after RIT-Z in patients with relapsed FL, previously exposed to rituximab. All patients with relapsed non-transformed, non-refractory, non-rituximab-naïve FL who have been treated with RIT-Z in two different centres in Europe were included. Staging and response were assessed by contrast-enhanced CT in all patients; PET/CT was performed according to local availability. Event-free survival (EFS) and time to next treatment (TTNT) following the last previous therapy and after RIT-Z were compared. Pre-therapy characteristics were tested in univariate analyses for prediction of outcomes. A description of the patterns of relapse was also provided. Among 70 patients treated, only 16 fulfilled the inclusion criteria. They were treated with a median of 3 prior lines of chemo-immunotherapies, including a median of 2 rituximab-containing regimens; 6 patients had undergone myeloablative chemotherapy with autologous stem cell rescue (ASCT). Overall response rates were 10 (62%) CR/CRu, 3 (19%) PR and 3 (19%) PD; response rates were similar in patients with prior ASCT. After RIT-Z only few patients obtained EFS and TTNT longer than after the last previous therapy. All four patients receiving rituximab maintenance were without progression 12 months after RIT-Z. Relapses occurred in both previously and newly involved sites; a significant association was found between the number of pathologic sites involved prior to RIT-Z and subsequent TTNT. Despite the excellent response rate, the duration of response was shorter than the previous one confirming the known trend of relapses to occur earlier after subsequent treatments. Rituximab maintenance after RIT-Z showed encouraging results in terms of prolonging EFS, warranting further studies. Copyright © 2010 John Wiley & Sons, Ltd.
Resumo:
Peatlands form in areas where net primary of organic matter production exceeds losses due to the decomposition, leaching or disturbance. Due to their chemical and physical characteristics, bogs can influence water dynamics because they can store large volumes of water in the rainy season and gradually release this water during the other months of the year. In Diamantina, Minas Gerais, Brazil, a peatland in the environmental protection area of Pau-de-Fruta ensures the water supply of 40,000 inhabitants. The hypothesis of this study is that the peat bogs in Pau-de-Fruta act as an environment for carbon storage and a regulator of water flow in the Córrego das Pedras basin. The objective of this study was to estimate the water volume and organic matter mass in this peatland and to study the influence of this environment on the water flow in the Córrego das Pedras basin. The peatland was mapped using 57 transects, at intervals of 100 m. Along all transects, the depth of the peat bog, the Universal Transverse Mercator (UTM) coordinates and altitude were recorded every 20 m and used to calculate the area and volume of the peatland. The water volume was estimated, using a method developed in this study, and the mass of organic matter based on samples from 106 profiles. The peatland covered 81.7 hectares (ha), and stored 497,767 m³ of water, representing 83.7 % of the total volume of the peat bog. The total amount of organic matter (OM) was 45,148 t, corresponding to 552 t ha-1 of OM. The peat bog occupies 11.9 % of the area covered by the Córrego das Pedras basin and stores 77.6 % of the annual water surplus, thus controlling the water flow in the basin and consequently regulating the water course.
Resumo:
The equivalence between the Lagrangian and Hamiltonian formalism is studied for constraint systems. A procedure to construct the Lagrangian constraints from the Hamiltonian constraints is given. Those Hamiltonian constraints that are first class with respect to the Hamiltonian constraints produce Lagrangian constraints that are FL-projectable.
Resumo:
Non-Hodgkin's lymphoma (NHL) comprises both indolent forms, including follicular lymphoma (FL) and marginal zone lymphoma (MZL), and aggressive forms, including diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL). FL and DLBCL are the most common subtypes of indolent and aggressive NHL, respectively. Although these lymphomas exhibit different clinical behaviors and outcomes, the prognosis is negatively affected in both DLBCL and FL by the lack of a complete response (CR) with standard treatment options. The aim of therapy should therefore be achievement of a CR, which is not only associated with longer progression-free survival (PFS) and overall survival times, but is also a prerequisite for a cure, particularly in DLBCL. Consolidation treatment with radioimmunotherapy (RIT) is an innovative treatment approach to increase CR rates. Phase II studies have indicated promising results with yttrium-90 ((90)Y)-ibritumomab tiuxetan and iodine-131 ((131)I)-tositumomab as consolidation following induction therapy for previously untreated patients with advanced FL. More recently, investigators reported a marked increase in CR rates and significant improvements in PFS using standard chemotherapy regimens followed by (90)Y-ibritumomab tiuxetan in a phase III randomized trial in patients with previously untreated FL. Data also suggest that RIT may play a role in the treatment of high-risk DLBCL, with encouraging PFS results from a phase II trial of (90)Y-ibritumomab tiuxetan consolidation following induction with rituximab plus chemotherapy in elderly patients with previously untreated DLBCL. With the higher CR rates and longer PFS times observed in patients with FL and DLBCL, as well as encouraging early data from MZL and MCL consolidation trials, RIT appears to have an important role in the treatment of patients with NHL.
Resumo:
PURPOSE Updated results are presented after a median follow-up of 7.3 years from the phase III First-Line Indolent Trial of yttrium-90 ((90)Y) -ibritumomab tiuxetan in advanced-stage follicular lymphoma (FL) in first remission. PATIENTS AND METHODS Patients with CD20(+) stage III or IV FL with complete response (CR), unconfirmed CR (CRu), or partial response (PR) after first-line induction treatment were randomly assigned to (90)Y-ibritumomab consolidation therapy (rituximab 250 mg/m(2) days -7 and 0, then (90)Y-ibritumomab 14.8 MBq/kg day 0; maximum 1,184 MBq) or no further treatment (control). Primary end point was progression-free survival (PFS) from date of random assignment. Results For 409 patients available for analysis ((90)Y-ibritumomab, n = 207; control, n = 202), estimated 8-year overall PFS was 41% with (90)Y-ibritumomab versus 22% for control (hazard ratio [HR], 0.47; P < .001). For patients in CR/CRu after induction, 8-year PFS with (90)Y-ibritumomab was 48% versus 32% for control (HR, 0.61; P = .008), and for PR patients, it was 33% versus 10% (HR, 0.38; P < .001). For (90)Y-ibritumomab consolidation, median PFS was 4.1 years (v 1.1 years for control; P < .001). Median time to next treatment (TTNT) was 8.1 years for (90)Y-ibritumomab versus 3.0 years for control (P < .001) with approximately 80% response rates to second-line therapy in either arm, including autologous stem-cell transplantation. No unexpected toxicities emerged during long-term follow-up. Estimated between-group 8-year overall survival rates were similar. Annualized incidence rate of myelodysplastic syndrome/acute myeloblastic leukemia was 0.50% versus 0.07% in (90)Y-ibritumomab and control groups, respectively (P = .042). CONCLUSION (90)Y-ibritumomab consolidation after achieving PR or CR/CRu to induction confers 3-year benefit in median PFS with durable 19% PFS advantage at 8 years and improves TTNT by 5.1 years for patients with advanced FL.
Resumo:
Objectives: The AMS 800 is the current artifi cial urinary sphincter (AUS) forincontinence due to intrinsic sphincter defi ciency. Despite good clinical results,technical failures inherent to the hydraulic mechanism or urethral ischemicinjury contribute to revisions up to 60%. We are developing an electronic AUS,called ARTUS to overcome the rigors of AMS. The objective of this study wasto evaluate the technical effi cacy and tissue tolerance of the ARTUS systemin an animal model.Methods: The ARTUS is composed by three parts: thecontractile unit, a series of rings and an integrated microprocessor. The contractileunit is made of Nitinol fi bers. The rings are placed around the urethrato control the fl ow of urine by squeezing the urethra. They work in a sequentialalternative mode and are controlled by a microprocessor. In the fi rst phase athree-rings device was used while in the second phase a two-rings ARTUS wasused. The device was implanted in 14 sheep divided in two groups of six andeight animals for study purpose. The fi rst group aimed at bladder leak pointpressure (BLPP) measurement and validation of the animal model; the secondgroup aimed at verifying midterm tissue tolerance by explants at twelve weeks.General animal tolerance was also evaluated.Results: The ARTUS systemimplantation was uneventful. When the system was activated, the BLPP wasmeasured at 1.038 ± 0.044 bar (mean ± SD). Urethral tissue analysis did notshow signifi cant morphological changes. No infection and no sign of discomfortwere noted in animals at 12 weeks.Conclusions: The ARTUS proved to beeffective in continence achievement in this study. Histological results supportour idea that a sequential alternative mode can avoid urethral atrophy andischemia. Further technical developments are needed to verify long-termoutcome and permit human use.
Resumo:
Na quantificação do intervalo hídrico ótimo (IHO), são utilizados diferentes limites críticos de resistência à penetração (RP) e umidade na capacidade de campo (θCC). Para solos agrícolas, esses valores estão sendo documentados na literatura. Entretanto, para solos construídos após mineração de carvão, constata-se grande lacuna de informações. O objetivo deste trabalho foi quantificar a faixa de variação do intervalo hídrico ótimo de um solo construído sob diferentes plantas de cobertura na área de mineração de carvão de Candiota, sul do Brasil, considerando diferentes limites críticos de umidade do solo na capacidade de campo e de resistência à penetração. Foram avaliadas no experimento, em blocos casualizados com quatro repetições, as seguintes plantas de cobertura: Hemártria (Hemarthria altissima (Poir.) Stapf & C. E. Hubbard), tratamento 1 (T1); Pensacola (Paspalum notatum Flüggé), tratamento 2 (T2); Grama Tifton (Cynodon dactilon (L.) Pers.), tratamento 3 (T3); Controle (Urochloa brizantha (Hochst.) Stapf), tratamento 4 (T4); e sem plantas de cobertura, tratamento 5 (T5). Para determinar o IHO, foram utilizados diferentes valores críticos de θCC referentes às tensões de 0,006; 0,01; e 0,033 MPa e RP de 1,5; 2,0; 2,5; e 3,0 MPa, mantendo-se sempre constante a umidade do solo no ponto de murcha permanente (θPMP) como sendo igual ao valor retido na tensão de 1,5 MPa e a umidade do solo em que a porosidade de aeração (PA) é de 10 %. A faixa de variação do IHO foi maior no solo construído cultivado com Urochloa brizantha; e a menor com Pensacola, independentemente dos limites críticos de θCC e de RP. Os limites críticos de θCC e de RP utilizados na definição do IHO originaram diferentes valores de densidade critica (Dsc) para o solo construído sob diferentes plantas de cobertura. Os menores e maiores valores de Dsc foram obtidos quando utilizados como limites críticos na definição do IHO, o θCC = 0,033 MPa e a RP = 3 MPa. O solo construído cultivado com Urochloa brizantha e Hemártria apresentou valor de Ds muito próximo ao de Dsc.
Resumo:
The objective of this analysis was to assess the radiation exposure associated with (90)Y-ibritumomab tiuxetan when used as consolidation therapy in adults with low or minimal tumor burden after first-line therapy of advanced follicular lymphoma (FL). METHODS: The patients who were enrolled in the phase 3 first-line indolent trial were 18 y or older, with CD20(+) grade 1 or 2 stage III or IV FL, and a partial response, complete response, or unconfirmed complete response to first-line chemotherapy. The patients were allocated randomly to receive a single infusion of unlabeled rituximab 250 mg/m(2) on day -7 and consolidation on day 0 with a single dose of (90)Y-ibritumomab tiuxetan, 14.8 MBq/kg, immediately after unlabeled rituximab, 250 mg/m(2), or no further treatment. On day -7, a subset of patients received an injection of 185 MBq of (111)In-ibritumomab tiuxetan immediately after unlabeled rituximab, 250 mg/m(2), for central dosimetry analysis. Correlations were assessed between organ radiation absorbed dose and toxicity, body weight, body mass index, and progression-free survival. RESULTS: Central dosimetry evaluations were available from 57 of 70 patients. Median radiation absorbed doses were 100 cGy (range, 28-327 cGy) for the red marrow and 72 cGy (range, 46-106 cGy) for the whole body. Radiation absorbed doses did not differ significantly between patients who had a partial response or complete response to initial therapy. Progression-free survival correlated significantly with the whole-body (r = 0.4401; P = 0.0006) and bone marrow (r = 0.2976; P = 0.0246) radiation dose. Body weight was significantly negatively correlated with whole-body radiation dose (r = -0.4971; P < 0.0001). Neither the whole-body radiation dose nor the bone marrow radiation dose correlated with hematologic toxicity. CONCLUSION: In patients with low or minimal residual tumor burden after first-line chemotherapy of advanced FL, whole-body and bone marrow exposure after (90)Y-ibritumomab tiuxetan consolidation showed a significant positive correlation with progression-free survival, whereas dosimetric data could not predict hematologic toxicity.
Resumo:
Introduction ICM+ software encapsulates our 20 years' experience in brain monitoring. It collects data from a variety of bedside monitors and produces time trends of parameters defi ned using confi gurable mathematical formulae. To date it is being used in nearly 40 clinical research centres worldwide. We present its application for continuous monitoring of cerebral autoregulation using near-infrared spectroscopy (NIRS). Methods Data from multiple bedside monitors are processed by ICM+ in real time using a large selection of signal processing methods. These include various time and frequency domain analysis functions as well as fully customisable digital fi lters. The fi nal results are displayed in a variety of ways including simple time trends, as well as time window based histograms, cross histograms, correlations, and so forth. All this allows complex information from bedside monitors to be summarized in a concise fashion and presented to medical and nursing staff in a simple way that alerts them to the development of various pathological processes. Results One hundred and fi fty patients monitored continuously with NIRS, arterial blood pressure (ABP) and intracranial pressure (ICP), where available, were included in this study. There were 40 severely headinjured adult patients, 27 SAH patients (NCCU, Cambridge); 60 patients undergoing cardiopulmonary bypass (John Hopkins Hospital, Baltimore) and 23 patients with sepsis (University Hospital, Basel). In addition, MCA fl ow velocity (FV) was monitored intermittently using transcranial Doppler. FV-derived and ICP-derived pressure reactivity indices (PRx, Mx), as well as NIRS-derived reactivity indices (Cox, Tox, Thx) were calculated and showed signifi cant correlation with each other in all cohorts. Errorbar charts showing reactivity index PRx versus CPP (optimal CPP chart) as well as similar curves for NIRS indices versus CPP and ABP were also demonstrated. Conclusions ICM+ software is proving to be a very useful tool for enhancing the battery of available means for monitoring cerebral vasoreactivity and potentially facilitating autoregulation guided therapy. Complexity of data analysis is also hidden inside loadable profi les, thus allowing investigators to take full advantage of validated protocols including advanced processing formulas.
Resumo:
OBJECTIVE: To explore how foot growth relates to musculoskeletal loading in children with Prader-Willi syndrome (PWS). STUDY DESIGN: In 37 children with PWS, foot length (FL) before and after 6 years of growth hormone therapy (GHT) was retrospectively evaluated with parental and sibling's FL, height, and factors reflecting musculoskeletal loading, such as weight for height (WfH), lean body mass (LBM; dual energy X-ray absorptiometry, deuterium labeled water), physical activity (accellerometry), and walk age. Because of the typically biphasic evolution of body mass and the late walk age in PWS, 2 age groups were separated (group 1, >2.5 years; group 2, < or =2.5 years). RESULTS: Children with PWS normalized height, but not FL after 6 years of GHT. Parental FL correlation with PWS's FL was lower than with sibling's FL. In group 1, FL positively correlated with WfH, LBM, and physical activity. In group 2, FL negatively correlated with age at onset of independent ambulation. Foot catch-up growth with GHT was slower in group 2 compared with group 1. CONCLUSION: In PWS, FL is positively associated with musculoskeletal loading. Small feet in children with PWS before and during long-term GHT may be more than just another dysmorphic feature, but may possibly reflect decreased musculoskeletal loading influencing foot growth and genetic and endocrine factors.